{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:49:30Z","timestamp":1793116170085,"version":"4.5.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1093\/carcin\/bgq118","type":"journal-article","created":{"date-parts":[[2010,6,11]],"date-time":"2010-06-11T01:03:22Z","timestamp":1276218202000},"page":"1475-1482","source":"Crossref","is-referenced-by-count":58,"title":["Effects of the TP53 p.R249S mutant on proliferation and clonogenic properties in human hepatocellular carcinoma cell lines: interaction with hepatitis B virus X protein"],"prefix":"10.1093","volume":"31","author":[{"given":"Doriane A.","family":"Gouas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s H.","family":"Hautefeuille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L.","family":"Ortiz-Cuaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9n\u00e9lope C.","family":"Legros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna J.","family":"Szymanska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Galy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars A.","family":"Egevad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnoush","family":"Abedi-Ardekani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klas G.","family":"Wiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Caron de Fromentel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle A.","family":"Chemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre L.","family":"Hainaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,6,10]]},"reference":[{"key":"key\n\t\t\t\t20170520235217_bib1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J. Clin."},{"key":"key\n\t\t\t\t20170520235217_bib2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1478-3231.2003.00869.x","article-title":"Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis","volume":"23","author":"Kew","year":"2003","journal-title":"Liver Int."},{"key":"key\n\t\t\t\t20170520235217_bib3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/350429a0","article-title":"Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa","volume":"350","author":"Bressac","year":"1991","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170520235217_bib4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/350427a0","article-title":"Mutational hotspot in the p53 gene in human hepatocellular carcinomas","volume":"350","author":"Hsu","year":"1991","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170520235217_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0165-1110(96)90005-6","article-title":"Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis","volume":"366","author":"Shen","year":"1996","journal-title":"Mutat. Res."},{"key":"key\n\t\t\t\t20170520235217_bib6","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1053\/j.gastro.2009.06.002","article-title":"In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure","volume":"137","author":"Besaratinia","year":"2009","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20170520235217_bib7","doi-asserted-by":"crossref","first-page":"8586","DOI":"10.1073\/pnas.90.18.8586","article-title":"Aflatoxin B1 induces the transversion of G\u2013>T in codon 249 of the p53 tumor suppressor gene in human hepatocytes","volume":"90","author":"Aguilar","year":"1993","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170520235217_bib8","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1038\/sj.onc.1202214","article-title":"The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts","volume":"17","author":"Denissenko","year":"1998","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170520235217_bib9","first-page":"6185","article-title":"Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens","volume":"51","author":"Puisieux","year":"1991","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170520235217_bib10","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc2693","article-title":"When mutants gain new powers: news from the mutant p53 field","volume":"9","author":"Brosh","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"key\n\t\t\t\t20170520235217_bib11","doi-asserted-by":"crossref","first-page":"a001107","DOI":"10.1101\/cshperspect.a001107","article-title":"Mutant p53 Gain-of-Function in Cancer","volume":"2","author":"Oren","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"key\n\t\t\t\t20170520235217_bib12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1535-6108(03)00079-5","article-title":"p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis","volume":"3","author":"Bergamaschi","year":"2003","journal-title":"Cancer Cell"},{"key":"key\n\t\t\t\t20170520235217_bib13","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1128\/MCB.21.5.1874-1887.2001","article-title":"A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain","volume":"21","author":"Gaiddon","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"key\n\t\t\t\t20170520235217_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/75586","article-title":"A common polymorphism acts as an intragenic modifier of mutant p53 behaviour","volume":"25","author":"Marin","year":"2000","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170520235217_bib15","doi-asserted-by":"crossref","first-page":"18817","DOI":"10.1074\/jbc.M201405200","article-title":"Physical interaction with human tumor-derived p53 mutants inhibits p63 activities","volume":"277","author":"Strano","year":"2002","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170520235217_bib16","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(94)90071-X","article-title":"Transcriptional activation by p53 correlates with suppression of growth but not transformation","volume":"79","author":"Crook","year":"1994","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170520235217_bib17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/carcin\/bgl132","article-title":"Inactive full-length p53 mutants lacking dominant wild-type p53 inhibition highlight loss-of-heterozygosity as an important aspect of p53 status in human cancers","volume":"28","author":"Dearth","year":"2007","journal-title":"Carcinogenesis"},{"key":"key\n\t\t\t\t20170520235217_bib18","first-page":"2103","article-title":"Effects of p53 mutants on wild-type p53-mediated transactivation are cell type dependent","volume":"10","author":"Forrester","year":"1995","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170520235217_bib19","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/sj.onc.1203434","article-title":"Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy","volume":"19","author":"Bullock","year":"2000","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170520235217_bib20","first-page":"2064","article-title":"Hepatocarcinoma-specific mutant p53-249ser induces mitotic activity but has no effect on transforming growth factor beta 1-mediated apoptosis","volume":"54","author":"Ponchel","year":"1994","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170520235217_bib21","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/hep.510270411","article-title":"The mouse equivalent of the human p53ser249 mutation p53ser246 enhances aflatoxin hepatocarcinogenesis in hepatitis B surface antigen transgenic and p53 heterozygous null mice","volume":"27","author":"Ghebranious","year":"1998","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20170520235217_bib22","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1073\/pnas.91.6.2230","article-title":"Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3","volume":"91","author":"Wang","year":"1994","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170520235217_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.25118","article-title":"Cooperation of tumor-derived HBx mutants and p53-249(ser) mutant in regulating cell proliferation, anchorage-independent growth and aneuploidy in a telomerase-immortalized normal human hepatocyte-derived cell line","author":"Jiang","year":"2010","journal-title":"Int. J. Cancer."},{"key":"key\n\t\t\t\t20170520235217_bib24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1099\/0022-1317-53-1-105","article-title":"Induction of hepatitis B surface antigen in human hepatoma-derived cell lines","volume":"53","author":"Oefinger","year":"1981","journal-title":"J. Gen. Virol."},{"key":"key\n\t\t\t\t20170520235217_bib25","doi-asserted-by":"crossref","first-page":"38847","DOI":"10.1074\/jbc.M205722200","article-title":"Hepatitis B virus X protein associated with UV-DDB1 induces cell death in the nucleus and is functionally antagonized by UV-DDB2","volume":"277","author":"Bontron","year":"2002","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170520235217_bib26","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1074\/jbc.M606774200","article-title":"The hepatitis B virus X protein functionally interacts with CREB-binding protein\/p300 in the regulation of CREB-mediated transcription","volume":"282","author":"Cougot","year":"2007","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170520235217_bib27","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1128\/MCB.17.10.5699","article-title":"Regulation of p53 by metal ions and by antioxidants: dithiocarbamate down-regulates p53 DNA-binding activity by increasing the intracellular level of copper","volume":"17","author":"Verhaegh","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"key\n\t\t\t\t20170520235217_bib28","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/ijc.20103","article-title":"Ser-249 TP53 mutation in tumour and plasma DNA of hepatocellular carcinoma patients from a high incidence area in the Gambia, West Africa","volume":"110","author":"Szyma\u00f1ska","year":"2004","journal-title":"Int. J. Cancer"},{"key":"key\n\t\t\t\t20170520235217_bib29","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1158\/1055-9965.EPI-08-1102","article-title":"TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China","volume":"18","author":"Szyma\u00f1ska","year":"2009","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"key\n\t\t\t\t20170520235217_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ijc.2910530111","article-title":"p53 mutations and aflatoxin B1 exposure in hepatocellular carcinoma patients from Thailand","volume":"53","author":"Hollstein","year":"1993","journal-title":"Int. J. Cancer"},{"key":"key\n\t\t\t\t20170520235217_bib31","doi-asserted-by":"crossref","first-page":"21934","DOI":"10.1074\/jbc.M604209200","article-title":"Effects of common cancer mutations on stability and DNA binding of full-length p53 compared with isolated core domains","volume":"281","author":"Ang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170520235217_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1359-6101(00)00034-4","article-title":"X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis","volume":"12","author":"Diao","year":"2001","journal-title":"Cytokine Growth Factor Rev."},{"key":"key\n\t\t\t\t20170520235217_bib33","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1038\/sj.onc.1201369","article-title":"Cytoplasmic retention of the p53 tumor suppressor gene product is observed in the hepatitis B virus X gene-transfected cells","volume":"15","author":"Takada","year":"1997","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170520235217_bib34","doi-asserted-by":"crossref","first-page":"14707","DOI":"10.1073\/pnas.94.26.14707","article-title":"Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis","volume":"94","author":"Elmore","year":"1997","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170520235217_bib35","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1158\/1078-0432.CCR-07-5082","article-title":"COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis","volume":"14","author":"Ma","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"key\n\t\t\t\t20170520235217_bib36","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jmb.2003.12.005","article-title":"Structural distortion of p53 by the mutation R249S and its rescue by a designed peptide: implications for \u201cmutant conformation\u201d","volume":"336","author":"Friedler","year":"2004","journal-title":"J. Mol. Biol."},{"key":"key\n\t\t\t\t20170520235217_bib37","doi-asserted-by":"crossref","first-page":"8424","DOI":"10.1073\/pnas.1431692100","article-title":"Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis","volume":"100","author":"Kato","year":"2003","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/31\/8\/1475\/17288540\/bgq118.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T22:20:02Z","timestamp":1740176402000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article-lookup\/doi\/10.1093\/carcin\/bgq118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,10]]},"references-count":37,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2010,6,10]]},"published-print":{"date-parts":[[2010,8]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgq118","relation":{},"ISSN":["1460-2180","0143-3334"],"issn-type":[{"value":"1460-2180","type":"electronic"},{"value":"0143-3334","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6,10]]}}}